Is Probably Benign Really Just Benign? Peter R Eby, MD, FSBI Virginia Mason Medical Center Seattle, WA

Size: px
Start display at page:

Download "Is Probably Benign Really Just Benign? Peter R Eby, MD, FSBI Virginia Mason Medical Center Seattle, WA"

Transcription

1 Is Probably Benign Really Just Benign? Peter R Eby, MD, FSBI Virginia Mason Medical Center Seattle, WA

2 Disclosures: CONSULTANT FOR DEVICOR MEDICAL

3 ARS Question 1 Is probably benign really just benign? A. Yes B. No

4 Overview Review the data related to BI-RADS 3 Mammography Ultrasound MRI Consider the probabilities

5 Is probably benign really just benign? MAMMOGRAPHY

6 BI-RADS 3: Research In 1991, Dr. Sickles published the results of a large prospective trial in which the patients and imaging findings had to meet strict criteria. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology, Vol 179(2); pp

7 BI-RADS 3: Strict Criteria The patient must: Undergo complete diagnostic work-up Not have prior films for comparison Prior exams allow us to determine if the finding is stable (benign, BI-RADS 2) or growing (suspicious, BI- RADS 4). Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology, Vol 179(2); pp

8 BI-RADS 3: Strict Criteria The mammographic finding must: Be non-palpable Adhere to one of these imaging descriptions: Group of punctate and/or round calcifications Smooth, round or oval, non-calcified mass Focally asymmetric tissue Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology, Vol 179(2); pp

9 Research Results: 34,282 women screened 3,184 with probably benign findings 3 or more years of follow-up Biopsy was performed if any finding grew during the follow-up period. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology, Vol 179(2); pp

10 Follow-up Protocol: This protocol adds a unilateral diagnostic mammogram at 6 months to the annual bilateral screening schedule. Initial screening & diagnostic mammogram 12 months: bilateral annual exam 24 months: bilateral annual exam 36 months: bilateral annual exam 6 months: unilateral follow-up 18 months: optional unilateral follow-up 30 months

11 Research Results: Type Malignant % Calcifications 2/ Masses 13/ Asymmetries 2/ Other 0/41 0 Total 17/ (45.2%) women completed the recommended follow up. 161 biopsies performed. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology, Vol 179(2); pp

12 Research Conclusions: When the guidelines are strictly followed the risk of malignancy for Probably Benign findings is LESS THAN 2%! Costs of biopsy including procedure time, recovery time, dollars and potential complications can be avoided. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology, Vol 179(2); pp

13 The Alternative View 1,234 calcifications cases and only 1 (0.1%) cancer 448 asymmetries and only 2 (0.4%) cancers 589 masses and 12 (2.0%) cancers Rubin E. Six-month follow-up: an alternative view. Radiology Oct;213(1):15-8; discussion

14

15 The Alternative View Anxious patients will get another opinion Few findings increase enough in 6 months to be detected Rubin E. Six-month follow-up: an alternative view. Radiology Oct;213(1):15-8; discussion

16 What is the Right Follow Up? Follow Up Interval Cancers Detected 6 months 6 12 months months 7 36 months 2 Isn t this when we would see patients with a BI-RADS 2 in follow up? Sickles EA. Probably benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol? Radiology Oct;213(1):11-4.

17 What is the Right Follow Up? 6 months may Catch aggressive cancers early Encourage continued follow up Appeal to some patients who don t like the idea of waiting an entire year

18 And How Have we Faired? Using BI-RADS 3 for other findings results in delayed diagnosis of more cancers. 3 years of screening with 3 years follow up Case-control study 1,711/82,898 (2.1%) exams with PB9 Lehman CD, Rutter CM, Eby PR et al. Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography. AJR. 2008;190(2): doi: /ajr

19 Caution 150 ipsilateral malignancies 8.8% cancer yield) 129 met study criteria and paired to control 258 exams assessed Only 52 (20%) met the strict PB9 criteria!

20 Caution 113 exams had prior films 27 malignant cases met PB9 criteria Cancer yield: 27/1,711 = 1.6% 57/63 (91%) cancer cases had prior exams showing growth

21 Caution Retrospective review of 295 PB9 cases 83 malignancies 51 corresponded to the PB9 finding Rosen EL, Baker JA, Soo MS. Malignant lesions initially subjected to short-term mammographic follow-up. Radiology. 2002;223(1):

22 Caution 0/51 met strict PB9 criteria 47/51 (92%) were already growing at the time of PB9 designation Rosen EL, Baker JA, Soo MS. Malignant lesions initially subjected to short-term mammographic follow-up. Radiology. 2002;223(1):

23 ARS Question 3 Regarding mammography, is probably benign really just benign? A. Yes B. No

24 Mammography Conclusions PB9 Works When A complete work-up is performed Morphology is respected Biopsy follows growth Radiologist delivers the recommendation directly to the patient PB9 Fails When Growing things are watched Other morphologies are included Patients don t follow up The message does not allay anxiety

25 Is probably benign really just benign? ULTRASOUND

26 Ultrasound: BI-RADS What Can We Follow? Solid mass with Circumscribed margin AND Oval shape AND Parallel orientation AND Hypoechoic to fat Isolated complicated cyst Clustered microcysts All NON-palpable! Mendelson EB, Böhm-Vélez M, Berg WA, et al. ACR BI-RADS Ultrasound. In: ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology;

27 Ultrasound What Can We Follow? Screening Ultrasound (ACRIN 6666) 20% of patients have probably benign findings 0.8% (6/745) of PB9 findings were malignant Barr RG, Zhang Z, Cormack JB, Mendelson EB, Berg WA. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial. Radiology Dec;269(3):

28 What about palpable lumps? ULTRASOUND

29 Following Palpable Masses Women Under 30 Retrospective review of women under 30 with focal signs and/or symptoms Biopsy, 24 month follow up or tumor registry 830 patients Loving, VA et al. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications. Am J of Roentgenology, 195(6),

30 Following Palpable Masses Women Under 30 BI-RADS Number Malignant 1 or (63.4%) (16.9%) (19.6%) 2 (1.2%) 5 1 (0.1%) 1 (100%) Total 830 (100%) 3 (0.4%) Age: (24) Sensitivity: 100% Specificity: 80.5% NPV: 100% PPV2: 1.8% PPV3: 1.9% Loving, VA et al. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications. Am J of Roentgenology, 195(6),

31 Following Palpable Masses Women Under 30 Focal breast signs or symptoms have a very low (0.4%) incidence of malignancy. 100% sensitivity and NPV of targeted ultrasound Primary imaging test in this clinical setting. No malignancies in BI-RADS 3 lesions Supports ultrasound surveillance over biopsy. Loving, VA et al. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications. Am J of Roentgenology, 195(6),

32 Following Palpable Masses Women Retrospective review of women with focal signs and/or symptoms Biopsy, 24 month follow-up or tumor registry 954 patients Lehman CD et al. Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women years of age. AJR Am J Roentgenol Nov;199(5): PMID

33 Following Palpable Masses Women BI-RADS Number Malignant 1 or (82.2%) 1 (0.1%)* 3 64 (5.3%) (11.5%) 12 (8.6%) 5 11 (0.9%) 10 (90.9%) Total 1208 (100%) 23 (1.9%) Age: (35) Sensitivity: 95.7% Specificity: 89.2% NPV: 99.9% PPV US: 13.2% PPV Mam: 18.4% *Mammography detected one a malignancy at another location in a 32 year old with BRCA mutation. Lehman CD et al. Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women years of age. AJR Am J Roentgenol Nov;199(5): PMID

34 Following Palpable Masses Women Mammography Ultrasound Sensitivity 60.9% 95.7% Specificity 94.4% 89.2% NPV 99.2% 99.9% PPV 18.4% 13.2% Ultrasound could be the primary imaging modality in this population. The added value of mammography was low. Lehman CD et al. Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women years of age. AJR Am J Roentgenol Nov;199(5): PMID

35 Following Palpable Masses Women Under 40 Retrospective review 263 lesions 4a s were 3 s that were palpable No malignancies Giess CS et al. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management. J Ultrasound Med Dec;31(12): PMID:

36 Following Palpable Masses Women Under 40 But fibroadenomas grow Biopsy when size increases by 20% in 6 months Gordon PB, Gagnon FA, Lanzkowsky L. Solid breast masses diagnosed as fibroadenoma at fineneedle aspiration biopsy: acceptable rates of growth at long-term follow-up. Radiology 2003; 229:

37 ARS Question 4 Regarding ultrasound, is probably benign really just benign? A. Yes B. No

38 Ultrasound Conclusions BI-RADS Says OK to follow non-palpable and isolated Circumscribed, oval, parallel, hypoechoic non-calcified masses Complicated cysts Clustered microcysts Considerations Palpable under 40 Circumscribed, oval, parallel, hypoechoic non-calcified masses Safe to follow May be safe for BI-RADS 2 Biopsy when size increases 20% in 6 months

39 Is probably benign really just benign? MRI

40 MRI: BI-RADS What Can We Follow? The specific morphologic and kinetic characteristics of lesions that can be appropriately assessed as MRI BI-RADS 3 remain undefined. We lack robust prospective data with outcomes.

41 MRI: BI-RADS What Can We Follow? Retrospective reviews Used in 11-24% of exams Malignant in % of cases No prospective trials of defined findings Low compliance with 6 month follow up

42 MRI: Probably Benign? Authors Year N Patients Cancer Yield Kuhl, et al /192 (13.5%) 1/26 (3.8%) Liberman, et al /367 (24%) 9/89 (10%) Eby, et al /1735 (13.5%) 2/236 (0.9%) Weinstein, et al /969 (10.9%) 1/106 (0.9%) These data come from retrospective analysis of findings assessed intuitively as probably benign. Some represent background enhancement. Indications for the MRIs were mixed.

43 MRI Population Is a selected higher risk population Risk of cancer at any moment may be greater than 2% Is subject to time pressure Higher likelihood of aggressive cancers

44 If You Use BI-RADS 3 for MRI Consider using mammography as a model Only for asymptomatic patients Only for baseline screening Prior exams allow downgrade to BI-RADS 2 for stable or decreasing lesions. Prior exams allow upgrade to BI-RADS 4 for growing or new lesions. Only after a complete work up: targeted ultrasound

45 If You Use BI-RADS 3 for MRI Recommend against using BI-RADS 3 in patients with a new diagnosis of cancer when evaluating the extent of disease. It leaves unanswered questions when therapeutic decisions are being made. Don t use it for background enhancement.

46 ARS Question 5 Regarding MRI, Is probably benign really just benign? A. Yes B. No

47 MRI Conclusions BI-RADS Says Robust prospective data are not available. Use extreme caution. Considerations Follow the mammogram model Baseline screening Complete the work up Not for diffuse bilateral findings

48 Is probably benign really just benign?

49 Is probably benign really just benign? WELL?

50 Is probably benign really just benign? WELL? IS IT?

51 Probable Conclusions Mammography: benign over 98% of the time when used correctly. Ultrasound: might always be benign in women with palpable lumps under 40 when used correctly. MRI: might just be suspicious.

52 THANK YOU

53 References: Mammography Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 1991;179(2): Varas X, Leborgne F, Leborgne JH. Nonpalpable, probably benign lesions: role of follow-up mammography. Radiology 1992;184(2): Wolfe JN, Buck KA, Salane M, Parekh NJ. Xeroradiography of the breast: overview of 21, 057 consecutive cases. Radiology 1987;165(2): Helvie MA, Pennes DR, Rebner M, Adler DD. Mammographic follow-up of low-suspicion lesions: compliance rate and diagnostic yield. Radiology 1991; 178(1): Vizcaíno I, Gadea L, Andreo L, et al. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography. Radiology 2001;219(2): Varas X, Leborgne JH, Leborgne F, Mezzera J, Jaumandreu S, Leborgne F. Revisiting the mammographic follow-up of BI-RADS category 3 lesions. AJR 2002; 179(3):

54 References: Ultrasound Berg WA, Sechtin AG, Marques H, Zhang Z. Cystic breast lesions and the ACRIN 6666 experience. Radiol Clin North Am 2010; 48: Berg WA, Blume JD, Cormack JB, Mendelson EB, Madsen EL. Lesion detection and characterization in a breast US phantom: results of the ACRIN 6666 Investigators. Radiology 2006; 239: Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 1991(2); 179: Mendelson EB, Böhm-Vélez M, Berg WA, et al. ACR BI-RADS Ultrasound. In: ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology; Loving, VA et al. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications. Am J of Roentgenology, 195(6), Lehman CD et al. Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women years of age. AJR Am J Roentgenol Nov;199(5): PMID Giess CS et al. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management. J Ultrasound Med Dec;31(12): PMID:

55 References: MRI Eby PR, DeMartini WB, Gutierrez RL, Lehman CD. Probably benign lesions detected on breast MR imaging. Magn Reson Imaging Clin N Am 2010;18: Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN Radiology 2010;255: Hauth E, Umutlu L, Kummel S, Kimmig R, Forsting M. Follow-up of probably benign lesions (BI-RADS 3 category) in breast MR imaging. Breast J 2010;16: Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD. Characteristics of probably benign breast MRI lesions. AJR Am J Roentgenol 2009;193: Liberman L, Morris EA, Benton CL, Abramson AF, Dershaw DD. Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women. Cancer 2003;98:

Management of Palpable Abnormalities in the Breast Katerina Dodelzon, MD July 31, 2018, 7:00pm ET

Management of Palpable Abnormalities in the Breast Katerina Dodelzon, MD July 31, 2018, 7:00pm ET Management of Palpable Abnormalities in the Breast Katerina Dodelzon, MD July 31, 2018, 7:00pm ET SAM Questions 1. 21 year old female presenting with left breast palpable mass, what is the most appropriate

More information

BI-RADS 3 category, a pain in the neck for the radiologist which technique detects more cases?

BI-RADS 3 category, a pain in the neck for the radiologist which technique detects more cases? BI-RADS 3 category, a pain in the neck for the radiologist which technique detects more cases? Poster No.: B-0966 Congress: ECR 2013 Type: Scientific Paper Authors: J. Etxano Cantera, I. Simon-Yarza, G.

More information

Rate of Malignancy in MRI-Detected Probably Benign (BI-RADS 3) Lesions

Rate of Malignancy in MRI-Detected Probably Benign (BI-RADS 3) Lesions Women s Imaging Original Research Spick et al. Malignancy in MRI BI-RADS 3 Lesions Women s Imaging Original Research Claudio Spick 1,2 Dieter H. M. Szolar 1 Pascal A. Baltzer 2 Manfred Tillich 1 Pia Reittner

More information

Short-term follow-up is the accepted management for mammographic lesions that are probably, but not definitely, benign. For these lesions to be classi

Short-term follow-up is the accepted management for mammographic lesions that are probably, but not definitely, benign. For these lesions to be classi Note: This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Frequency of Malignancy

More information

Short-Term Follow-Up of Palpable Breast Lesions With Benign Imaging Features: Evaluation of 375 Lesions in 320 Women

Short-Term Follow-Up of Palpable Breast Lesions With Benign Imaging Features: Evaluation of 375 Lesions in 320 Women Women s Imaging Original Research Follow-Up Imaging of Palpable Breast Lesions Women s Imaging Original Research WOMEN S IMAGING Jennifer A. Harvey 1 Brandi T. Nicholson 1 Alexander P. LoRusso 1,2 Michael

More information

ACR Appropriateness Criteria on Nonpalpable Mammographic Findings (Excluding Calcifications)

ACR Appropriateness Criteria on Nonpalpable Mammographic Findings (Excluding Calcifications) ACR Appropriateness Criteria on Nonpalpable Mammographic Findings (Excluding Calcifications) Mary S. Newell, MD a, Robyn L. Birdwell, MD b, Carl J. D Orsi, MD c, Lawrence W. Bassett, MD d, Mary C. Mahoney,

More information

BI-RADS Categorization As a Predictor of Malignancy 1

BI-RADS Categorization As a Predictor of Malignancy 1 Susan G. Orel, MD Nicole Kay, BA Carol Reynolds, MD Daniel C. Sullivan, MD BI-RADS Categorization As a Predictor of Malignancy 1 Index terms: Breast, biopsy, 00.1261 Breast neoplasms, localization, 00.125,

More information

Positive Predictive Value of

Positive Predictive Value of Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Mary C. Mahoney,

More information

Multiple Bilateral Circumscribed Masses at Screening Breast US: Consider Annual Follow-up 1

Multiple Bilateral Circumscribed Masses at Screening Breast US: Consider Annual Follow-up 1 Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Wendie A. Berg, MD,

More information

S. Murgo, MD. Chr St-Joseph, Mons Erasme Hospital, Brussels

S. Murgo, MD. Chr St-Joseph, Mons Erasme Hospital, Brussels S. Murgo, MD Chr St-Joseph, Mons Erasme Hospital, Brussels? Introduction Mammography reports are sometimes ambiguous and indecisive. ACR has developped the BIRADS. BIRADS consists of a lexicon in order

More information

ISSN X (Print) Research Article. *Corresponding author Dr. Amlendu Nagar

ISSN X (Print) Research Article. *Corresponding author Dr. Amlendu Nagar Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2015; 3(3A):1069-1073 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources)

More information

Risk of Malignancy in Palpable Solid Breast Masses Considered Probably Benign or Low Suspicion

Risk of Malignancy in Palpable Solid Breast Masses Considered Probably Benign or Low Suspicion ORIGINAL RESEARCH Risk of Malignancy in Palpable Solid Breast Masses Considered Probably Benign or Low Suspicion Implications for Management Catherine S. Giess, MD, Lisa Zorn Smeglin, MD, Jack E. Meyer,

More information

ACRIN 6666 IM Additional Evaluation: Additional Views/Targeted US

ACRIN 6666 IM Additional Evaluation: Additional Views/Targeted US Additional Evaluation: Additional Views/Targeted US For revised or corrected form check box and fax to 215-717-0936. Instructions: The form is completed based on recommendations (from ID form) for additional

More information

Amammography report is a key component of the breast

Amammography report is a key component of the breast Review Article Writing a Mammography Report Amammography report is a key component of the breast cancer diagnostic process. Although mammographic findings were not clearly differentiated between benign

More information

Leonard M. Glassman MD

Leonard M. Glassman MD BI-RADS The New BI-RADS Leonard M. Glassman MD FACR Former Chief of Breast Imaging American Institute for Radiologic Pathology Washington Radiology Associates, PC Breast Imaging Reporting and Data System

More information

National Diagnostic Imaging Symposium 2013 SAM - Breast MRI 1

National Diagnostic Imaging Symposium 2013 SAM - Breast MRI 1 National Diagnostic Imaging Symposium 2013 December 8-12, 2013 Disney s Yacht Club Resort Lake Buena Vista, Florida Self Assessment Module Questions, Answers and References Day SAM Title - Each SAM title

More information

UW Radiology Review Course Breast Calcifications. BI-RADS 5 th Edition

UW Radiology Review Course Breast Calcifications. BI-RADS 5 th Edition UW Radiology Review Course Breast Calcifications Grace Kalish, MD Vantage Radiology BI-RADS 5 th Edition Benign Skin Vascular Large rod like Coarse popcorn Suspicious Amorphous Coarse heterogenous Fine

More information

New Palpable Breast Lump With Recent Negative Mammogram: Is Repeat Mammography Necessary?

New Palpable Breast Lump With Recent Negative Mammogram: Is Repeat Mammography Necessary? Women s Imaging Original Research Leung et al. Repeat Mammogram for Breast Lump Found After Negative Mammogram Women s Imaging Original Research Stephanie E. Leung 1 Ilanit Ben-Nachum Anat Kornecki Leung

More information

Imaging the Symptomatic Patient. Avice M.O Connell MD,FACR,FSBI Professor of Imaging Sciences Director, Women s Imaging University of Rochester

Imaging the Symptomatic Patient. Avice M.O Connell MD,FACR,FSBI Professor of Imaging Sciences Director, Women s Imaging University of Rochester Imaging the Symptomatic Patient Avice M.O Connell MD,FACR,FSBI Professor of Imaging Sciences Director, Women s Imaging University of Rochester The four most common symptoms Mass Pain Discharge Infection

More information

Diagnostic Dilemmas of Breast Imaging

Diagnostic Dilemmas of Breast Imaging Diagnostic Dilemmas of Breast Imaging Common Causes of Error in Breast Cancer Detection By: Jason Cord, M.D. Mammography: Initial Imaging The standard for detection of breast cancer Screening mammography

More information

Pitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania

Pitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania Pitfalls and Limitations of Breast MRI Susan Orel Roth, MD Professor of Radiology University of Pennsylvania Objectives Review the etiologies of false negative breast MRI examinations Discuss the limitations

More information

MRI BI-RADS: How to make it out?

MRI BI-RADS: How to make it out? MRI BI-RADS: How to make it out? Poster No.: C-1850 Congress: ECR 2016 Type: Educational Exhibit Authors: M. Ben Ammar, A. Ben Miled, O. Ghdes, S. Harguem, A. Gaja, N. Mnif; Tunis/TN Keywords: Breast,

More information

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign Quality ID #146 (NQF 0508): Radiology: Inappropriate Use of Probably Benign Assessment Category in Screening Mammograms National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS F INDIVIDUAL

More information

What s New in Breast Imaging. Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia

What s New in Breast Imaging. Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia What s New in Breast Imaging Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia Disclosure Hologic, Inc. Shareholder and research agreement. Volpara Solutions, Ltd. Shareholder

More information

Tips and Tricks to performing Magnetic Resonance Imaging Guided Breast Interventional Procedures Habib Rahbar, MD, FSBI October 23, 2018, 7:00pm ET

Tips and Tricks to performing Magnetic Resonance Imaging Guided Breast Interventional Procedures Habib Rahbar, MD, FSBI October 23, 2018, 7:00pm ET Tips and Tricks to performing Magnetic Resonance Imaging Guided Breast Interventional Procedures Habib Rahbar, MD, FSBI October 23, 2018, 7:00pm ET SAM Questions/Answers/Rationales/References 1. Below

More information

Breast Imaging Lexicon

Breast Imaging Lexicon 9//201 200 BI RADS th Edition 201 BI RADS th Edition Breast Imaging Lexicon Mammographic Pathology and Assessment Categories Deborah Thames, R.T.(R)(M)(QM) The Advanced Health Education Center Nonmember:

More information

Pathologic outcomes of coarse heterogeneous calcifications detected on mammography

Pathologic outcomes of coarse heterogeneous calcifications detected on mammography Pathologic outcomes of coarse heterogeneous calcifications detected on mammography Poster No.: C-1957 Congress: ECR 2011 Type: Scientific Paper Authors: H. J. Lim, K. R. Cho, K. W. Hwang, B. K. Seo, O.

More information

BI-RADS Update. Martha B. Mainiero, MD, FACR, FSBI Brown University Rhode Island Hospital

BI-RADS Update. Martha B. Mainiero, MD, FACR, FSBI Brown University Rhode Island Hospital BI-RADS Update Martha B. Mainiero, MD, FACR, FSBI Brown University Rhode Island Hospital No Disclosures BI-RADS History 1980s Quality Issues ACR Accreditation BI-RADS 1994 2003 4 th Edition MRI, US January

More information

Spiculated breast masses on MRI: Which category should we choose, 4 or 5?

Spiculated breast masses on MRI: Which category should we choose, 4 or 5? Spiculated breast masses on MRI: Which category should we choose, 4 or 5? Poster No.: C-1394 Congress: ECR 2015 Type: Scientific Exhibit Authors: N. Onishi, S. Kanao, M. Kataoka, M. Kawai, M. Iima, A.

More information

BCSC Glossary of Terms (Last updated 09/16/2009) DEFINITIONS

BCSC Glossary of Terms (Last updated 09/16/2009) DEFINITIONS Screening mammography scrmam_c BCSC Glossary of Terms (Last updated 09/16/2009) DEFINITIONS The radiologist s indication for exam is the primary determinant of whether a mammogram is screening or diagnostic.

More information

Usefulness of ultrasound elastography in reducing the number of Breast Imaging Reporting and Data System category 3 lesions on ultrasonography

Usefulness of ultrasound elastography in reducing the number of Breast Imaging Reporting and Data System category 3 lesions on ultrasonography Usefulness of ultrasound elastography in reducing the number of Breast Imaging Reporting and Data System category 3 lesions on ultrasonography Nariya Cho, Jihe Lim, Woo Kyung Moon Department of Radiology,

More information

Epworth Healthcare Benign Breast Disease Symposium. Sat Nov 12 th 2016

Epworth Healthcare Benign Breast Disease Symposium. Sat Nov 12 th 2016 Epworth Healthcare Benign Breast Disease Symposium Breast cancer is common Sat Nov 12 th 2016 Benign breast disease is commoner, and anxiety about breast disease commoner still Breast Care Campaign UK

More information

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign Measure #146 (NQF 0508): Radiology: Inappropriate Use of Probably Benign Assessment Category in Screening Mammograms National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS F

More information

The Breast Imaging Reporting and Data System (BI-RADS) has standardized the description and management of findings identified on mammograms, thereby f

The Breast Imaging Reporting and Data System (BI-RADS) has standardized the description and management of findings identified on mammograms, thereby f ORIGINAL RESEARCH BREAST IMAGING Elizabeth S. Burnside, MD, MPH, MS Jennifer E. Ochsner, MD Kathryn J. Fowler, MD Jason P. Fine, PhD Lonie R. Salkowski, MD Daniel L. Rubin, MD, MS Gale A. Sisney, MD Use

More information

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since Imaging in breast cancer Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since A mammogram report is a key component of the breast cancer diagnostic process. A mammogram

More information

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of

More information

Accuracy of Diagnostic Mammography and Breast Ultrasound During Pregnancy and Lactation

Accuracy of Diagnostic Mammography and Breast Ultrasound During Pregnancy and Lactation Women s Imaging Original Research Robbins et al. Mammography and Ultrasound During Pregnancy and Lactation Women s Imaging Original Research Jessica Robbins 1 Deborah Jeffries 2 Marilyn Roubidoux 2 Mark

More information

BREAST IMAGING and NEW IMAGING MODALITIES- A Surgeons view

BREAST IMAGING and NEW IMAGING MODALITIES- A Surgeons view BREAST IMAGING and NEW IMAGING MODALITIES- A Surgeons view DR CHANTEL THORNTON SPECIALIST BREAST CANCER SURGEON BMSc (hons) MBBS (hons) FRACS Epworth Hospital, Richmond- Agora Centre for Women s Health

More information

Table 1. Classification of US Features Based on BI-RADS for US in Benign and Malignant Breast Lesions US Features Benign n(%) Malignant n(%) Odds

Table 1. Classification of US Features Based on BI-RADS for US in Benign and Malignant Breast Lesions US Features Benign n(%) Malignant n(%) Odds 215 Table 1. Classification of US Features Based on BI-RADS for US in Benign and Malignant Breast Lesions US Features Benign n(%) Malignant n(%) Odds ratio 719 (100) 305(100) Shape Oval 445 (61.9) 019

More information

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB)

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB) Original article Annals of Oncology 14: 450 454, 2003 DOI: 10.1093/annonc/mdh088 Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB)

More information

Breast Imaging Donald L. Renfrew, MD

Breast Imaging Donald L. Renfrew, MD This free educational material is provided by 333 N. Commercial Street, Suite 100, Neenah, WI 54956 Donald L. Renfrew, MD Breast cancer is the most frequent non-skin cancer diagnosis in women, with an

More information

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of

More information

Does elastography change the indication to biopsy? IBDC

Does elastography change the indication to biopsy? IBDC Does elastography change the indication to biopsy? A LEXANDRA A THANASIOU, M D DEPARTMENT OF RADIOLOGY CURIE INSTITUTE PARIS, FRANCE IBDC Ultrasound Detected Cancers Physician-performed ultrasound increases

More information

Developing Asymmetry Identified on Mammography: Correlation with Imaging Outcome and Pathologic Findings

Developing Asymmetry Identified on Mammography: Correlation with Imaging Outcome and Pathologic Findings Asymmetry on Mammography Women s Imaging Original Research WOMEN S IMAGING Jessica W. T. Leung 1 Edward A. Sickles Leung JWT, Sickles EA Keywords: breast, breast cancer, mammography, screening, sonography

More information

MRI Occult Invasive Breast Cancer

MRI Occult Invasive Breast Cancer MRI Occult Invasive Breast Cancer Poster No.: C-1573 Congress: ECR 2015 Type: Educational Exhibit Authors: R. Patel, N. Chhaya, K. Stafford, B. Holloway, D. Tsukagoshi, A. Malhotra; London/ Keywords: Cancer,

More information

Triple Receptor Negative Breast Cancer: Imaging and Clinical Characteristics

Triple Receptor Negative Breast Cancer: Imaging and Clinical Characteristics Women s Imaging Original Research Krizmanich-Conniff et al. Triple Receptor Negative Breast Cancer Women s Imaging Original Research Kristin M. Krizmanich-Conniff 1 Chintana Paramagul 2 Stephanie K. Patterson

More information

Breast Cancer Imaging

Breast Cancer Imaging Breast Cancer Imaging I. Policy University Health Alliance (UHA) will cover breast imaging when such services meet the medical criteria guidelines (subject to limitations and exclusions) indicated below.

More information

Triple-negative breast cancer: which typical features can we identify on conventional and MRI imaging?

Triple-negative breast cancer: which typical features can we identify on conventional and MRI imaging? Triple-negative breast cancer: which typical features can we identify on conventional and MRI imaging? Poster No.: C-1862 Congress: ECR 2013 Type: Educational Exhibit Authors: V. Bertani 1, A. Gualano

More information

Disclosures. Breast Cancer. Breast Imaging Modalities. Breast Cancer Screening. Breast Cancer 6/4/2014

Disclosures. Breast Cancer. Breast Imaging Modalities. Breast Cancer Screening. Breast Cancer 6/4/2014 : Information for the Primary Care Physician Disclosures No financial relationships with commercial entities producing health care products/services. Roxsann Roberts, MD Section Chief, MRI Erlanger/EmCare

More information

Electrical impedance scanning of the breast is considered investigational and is not covered.

Electrical impedance scanning of the breast is considered investigational and is not covered. ARBenefits Approval: 09/28/2011 Effective Date: 01/01/2012 Revision Date: Code(s): Medical Policy Title: Electrical Impedance Scanning of the Breast Document: ARB0127 Administered by: Public Statement:

More information

Clinical Data as an Adjunct to Ultrasound Reduces the False-Negative Malignancy Rate in BI-RADS 3 Breast Lesions

Clinical Data as an Adjunct to Ultrasound Reduces the False-Negative Malignancy Rate in BI-RADS 3 Breast Lesions THIEME E83 Clinical Data as an Adjunct to Ultrasound Reduces the False-Negative Malignancy Rate in BI-RADS 3 Breast Lesions Authors S. Ackermann 1, C.-A. Schoenenberger 2, R. Zanetti-Dällenbach 3 Affiliations

More information

Value of the BI-RADS classification in MR-Mammography for diagnosis of benign and malignant breast tumors

Value of the BI-RADS classification in MR-Mammography for diagnosis of benign and malignant breast tumors Eur Radiol (2011) 21:2475 2483 DOI 10.1007/s00330-011-2210-7 BREAST Value of the BI-RADS classification in MR-Mammography for diagnosis of benign and malignant breast tumors Christian Sohns & Martin Scherrer

More information

E94. Aims and Objectives To assess whether it is possible to establish. received revised accepted

E94. Aims and Objectives To assess whether it is possible to establish. received revised accepted Can Cut-Off-Values for Tumor Size or Patient Age in Breast Ultrasound Reduce Unnecessary Biopsies or is it all About Bi-rads? A Retrospective Analysis of 763 Biopsied T1-Sized Lesions Authors Laura Holzer-Fruehwald

More information

The Sonographic Findings and Differing Clinical Implications of Simple, Complicated, and Complex Breast Cysts

The Sonographic Findings and Differing Clinical Implications of Simple, Complicated, and Complex Breast Cysts 1101 The Sonographic Findings and Differing Clinical Implications of Simple, Complicated, and Complex Breast Cysts John G. Huff, MD, Nashville, Tennessee Key Words Fibrocystic condition, fibrocystic change,

More information

BR 1 Palpable breast lump

BR 1 Palpable breast lump BR 1 Palpable breast lump Palpable breast lump in patient 40 years of age or above MMG +/- spot compression or digital breast tomosynthesis over palpable findings Suspicious or malignant findings (BIRADS

More information

Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666

Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666 JNCI J Natl Cancer Inst (2016) 108(4): djv367 doi:10.1093/jnci/djv367 First published online December 28, 2015 Article Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666

More information

Improving Reading Time of Digital Breast Tomosynthesis with Concurrent Computer Aided Detection

Improving Reading Time of Digital Breast Tomosynthesis with Concurrent Computer Aided Detection White Paper Improving Reading Time of Digital Breast Tomosynthesis with Concurrent Computer Aided Detection WHITE PAPER 2 3 Abstract PowerLook Tomo Detection, a concurrent computer-aided detection (CAD)

More information

Dense Breasts, Get Educated

Dense Breasts, Get Educated Dense Breasts, Get Educated What are Dense Breasts? The normal appearances to breasts, both visually and on mammography, varies greatly. On mammography, one of the important ways breasts differ is breast

More information

Breast asymmetries in mammography: Management

Breast asymmetries in mammography: Management Breast asymmetries in mammography: Management Poster No.: C-1026 Congress: ECR 2015 Type: Educational Exhibit Authors: V. de Lara Bendahan 1, F. J. Hidalgo Ramos 2, J. L. Ortega Garcia 3, Keywords: DOI:

More information

Medical Audit of Diagnostic Mammography Examinations: Comparison with Screening Outcomes Obtained Concurrently

Medical Audit of Diagnostic Mammography Examinations: Comparison with Screening Outcomes Obtained Concurrently Katherine E. Dee 1,2 Edward A. Sickles 1 Received July 3, 2000; accepted after revision September 12, 2000. Presented in part at the annual meeting of the American Roentgen Ray Society, Washington, DC,

More information

BI-RADS and Breast MRI. Kathy Borovicka, M.D. Thursday February 15, 2018

BI-RADS and Breast MRI. Kathy Borovicka, M.D. Thursday February 15, 2018 BI-RADS and Breast MRI Kathy Borovicka, M.D. Thursday February 15, 2018 Learning Objectives Be familiar with the Breast Imaging Reporting and Data System (BI-RADS) Understand the components of a breast

More information

Imaging Management of Palpable Breast Abnormalities

Imaging Management of Palpable Breast Abnormalities Women s Imaging Best Practices/Review Lehman et al. Imaging of Breast Abnormalities Women s Imaging Best Practices/Review Constance D. Lehman 1 Amie Y. Lee Christoph I. Lee Lehman CD, Lee AY, Lee CI Keywords:

More information

Over the recent decades, breast ultrasonography (US) has

Over the recent decades, breast ultrasonography (US) has ORIGINAL RESEARCH Application of Computer-Aided Diagnosis on Breast Ultrasonography Evaluation of Diagnostic Performances and Agreement of Radiologists According to Different Levels of Experience Eun Cho,

More information

MATERIALS AND METHODS

MATERIALS AND METHODS Breast Imaging Edward A. Sickles, MD Periodic Follow-up of Probably Benign Lesions: Results in 3,184 Consecutive Cases The author prospectively evaluated the value of periodic mammographic surveillance

More information

Yonsei University, College of Medicine, 5 Department of Radiology, Soonchunhyang University Bucheon Hospital,

Yonsei University, College of Medicine, 5 Department of Radiology, Soonchunhyang University Bucheon Hospital, Original Article Interobserver Variability and Diagnostic Performance with the Fifth Edition of the ACR BI-RADS Lexicon for Ultrasound; Validation from Multi-institutions Sung Hun Kim 1, Dong Wook Kim

More information

Solitary Dilated Duct Identified at Mammography: Outcomes Analysis

Solitary Dilated Duct Identified at Mammography: Outcomes Analysis Women s Imaging Original Research Mammography of Solitary Dilated Duct Chang et al. Women s Imaging Original Research FOCUS ON: C. Belinda Chang 1 Natalya M. Lvoff 2 Jessica W. Leung 3 R. James Brenner

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD Non-mass Enhancement on Breast MRI Aditi A. Desai, MD Margaret Ann Mays, MD Breast MRI Important screening and diagnostic tool, given its high sensitivity for breast cancer detection Breast MRI - Indications

More information

Accuracy and Value of Breast Ultrasound for Primary Imaging Evaluation of Symptomatic Women Years of Age

Accuracy and Value of Breast Ultrasound for Primary Imaging Evaluation of Symptomatic Women Years of Age Women s Imaging Original Research Lehman et al. Breast Ultrasound for Primary Imaging Evaluation Women s Imaging Original Research Constance D. Lehman 1,2 Christoph I. Lee 1,2 Vilert A. Loving 1,2 Michael

More information

Observer Agreement Using the ACR Breast Imaging Reporting and Data System (BI-RADS)-Ultrasound, First Edition (2003)

Observer Agreement Using the ACR Breast Imaging Reporting and Data System (BI-RADS)-Ultrasound, First Edition (2003) Observer Agreement Using the ACR Breast Imaging Reporting and Data System (BI-RADS)-Ultrasound, First Edition (2003) Chang Suk Park, MD 1 Jae Hee Lee, MD 2 Hyeon Woo Yim, MD 3 Bong Joo Kang, MD 4 Hyeon

More information

BI-RADS classification in breast tomosynthesis. Our experience in breast cancer cases categorized as BI-RADS 0 in digital mammography

BI-RADS classification in breast tomosynthesis. Our experience in breast cancer cases categorized as BI-RADS 0 in digital mammography BI-RADS classification in breast tomosynthesis. Our experience in breast cancer cases categorized as BI-RADS 0 in digital mammography Poster No.: C-0562 Congress: ECR 2017 Type: Scientific Exhibit Authors:

More information

BREAST MRI. VASILIKI FILIPPI RADIOLOGIST CT MRI & PET/CT Departments Hygeia Hospital, Athens, Greece

BREAST MRI. VASILIKI FILIPPI RADIOLOGIST CT MRI & PET/CT Departments Hygeia Hospital, Athens, Greece BREAST MRI VASILIKI FILIPPI RADIOLOGIST CT MRI & PET/CT Departments Hygeia Hospital, Athens, Greece Breast ΜR Imaging (MRM) Breast MR imaging is an extremely powerful diagnostic tool, that when used in

More information

Patient Outcomes in Canceled MRI-Guided Breast Biopsies

Patient Outcomes in Canceled MRI-Guided Breast Biopsies Women s Imaging Original Research Outcomes After Canceled MRI-Guided Breast Biopsies Women s Imaging Original Research Bethany L. Niell 1 Janie M. Lee 1, 2 Christopher Johansen 3 Elkan F. Halpern 4 Elizabeth

More information

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine Overview Rationale for new imaging

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

COMPARISON OF MAMMOGRAPHY AND ULTRASOUND COMBINED VERSUS ULTRASOUND ALONE IN EARLY EVALUATION OF SYMPTOMATIC BREAST CANCERS IN PAKISTAN

COMPARISON OF MAMMOGRAPHY AND ULTRASOUND COMBINED VERSUS ULTRASOUND ALONE IN EARLY EVALUATION OF SYMPTOMATIC BREAST CANCERS IN PAKISTAN COMPARISON OF MAMMOGRAPHY AND ULTRASOUND COMBINED VERSUS ULTRASOUND ALONE IN EARLY EVALUATION OF SYMPTOMATIC BREAST CANCERS IN PAKISTAN Razia Bano 1, Huma M. Khan 2, Ayesha Ehsan 1, Awais A. Malik 2, Shahper

More information

University of Washington Radiology Review Course: Strange and Specific Diagnoses. Case #1

University of Washington Radiology Review Course: Strange and Specific Diagnoses. Case #1 University of Washington Radiology Review Course: Strange and Specific Diagnoses Katherine E. Dee, MD Seattle Breast Center Via Radiology 2014 Case #1 37 year old presents with bilateral palpable lumps.

More information

Current Status of Supplementary Screening With Breast Ultrasound

Current Status of Supplementary Screening With Breast Ultrasound Current Status of Supplementary Screening With Breast Ultrasound Stephen A. Feig, M.D., FACR Fong and Jean Tsai Professor of Women s Imaging Department of Radiologic Sciences University of California,

More information

CDIS: what's beyond microcalcifications? - Pictorial essay

CDIS: what's beyond microcalcifications? - Pictorial essay CDIS: what's beyond microcalcifications? - Pictorial essay Poster No.: C-1096 Congress: ECR 2014 Type: Educational Exhibit Authors: R. N. Lucas, C. A. S. Ruano, I. Oliveira, J. M. G. Lourenco, Z. 1 1 1

More information

Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization

Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 5, 2015 Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization Jie Huang, a Sarah M. Schafer,

More information

«àπ π â Õ μ «å «π Áß μâ π π ßæ π ª

«àπ π â Õ μ «å «π Áß μâ π π ßæ π ª «æ å μ Ù-ı ªï Ë Ûapple Ë Ù μ.. -.. ÚııÙ Reg 4-5 Med J Vol. 30 No. 4 Oct - Dec 2011 π æπ åμâπ Original Article «μ»ÿ º æ.., Cheerawan Tansupaphon M.D., «.«. ß «π Thai Board of Diagnostic Radiology ÿà ß π

More information

Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM am am : Clinician s requirements from breast imaging

Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM am am : Clinician s requirements from breast imaging Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM 2012 Day one, 2 nd November BREAST IMAGING AND INTERVENTIONS PROGRAM 2012 9.00 AM 9.10 am Introduction 9.10 am - 9.30 am : Clinician

More information

Validation of the fifth edition BI-RADS ultrasound lexicon with comparison of fourth and fifth edition diagnostic performance using video clips

Validation of the fifth edition BI-RADS ultrasound lexicon with comparison of fourth and fifth edition diagnostic performance using video clips Validation of the fifth edition BI-RADS ultrasound lexicon with comparison of fourth and fifth edition diagnostic performance using video clips Jung Hyun Yoon 1, Min Jung Kim 1, Hye Sun Lee 2, Sung Hun

More information

AMSER Case of the Month: November 2018

AMSER Case of the Month: November 2018 AMSER Case of the Month: November 2018 52 year old female with an abnormal screening mammogram Areeg Rehman, MS 4 Nova Southeastern University Rebecca T. Sivarajah, MD Penn State University College of

More information

Screening with New Modalities: Breast Ultrasound

Screening with New Modalities: Breast Ultrasound Screening with New Modalities: Breast Ultrasound Wendie A. Berg, MD, PhD Professor of Radiology Magee-Womens Hospital of UPMC University of Pittsburgh School of Medicine Disclosures No personal financial

More information

Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer

Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Early Detection and Diagnosis Early Detection and Diagnosis Version 2005: Junkermann Version 2006 2009: Schreer / Albert Version

More information

MEDICAL IMAGING AND BREAST DISEASE HOW CAN WE HELP YOU?

MEDICAL IMAGING AND BREAST DISEASE HOW CAN WE HELP YOU? MEDICAL IMAGING AND BREAST DISEASE HOW CAN WE HELP YOU? Barbara M. Preston, M.D. SCREENING MAMMOGRAPHY AVERAGE RISK PATIENTS KAISER RECOMMENDATION: ALL WOMEN (INCLUDING TRANSGENDER FEMALES) Every 1-21

More information

JMSCR Vol 05 Issue 04 Page April 2017

JMSCR Vol 05 Issue 04 Page April 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i4.57 Efficacy of Mammography in Detecting Breast

More information

Breast Cancer Screening and Diagnosis

Breast Cancer Screening and Diagnosis Breast Cancer Screening and Diagnosis Priya Thomas, MD Assistant Professor Clinical Cancer Prevention and Breast Medical Oncology University of Texas MD Anderson Cancer Center Disclosures Dr. Thomas has

More information

Dr Robin Wilson, The Royal Marsden

Dr Robin Wilson, The Royal Marsden Screening: State of the Art High risk and dense breasts Robin Wilson Smart Breast Screening? 1 in 8 women in the will get breast cancer 8 in 9 will not 55% of breast cancers are not screen detected One

More information

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Breast Cancer Most common cancer in American women 180,000 new cases per year Second most common cause of cancer death 44,000

More information

Correlation between MRI & biopsies under second look Ultrasound

Correlation between MRI & biopsies under second look Ultrasound Correlation between MRI & biopsies under second look Ultrasound Anne de Roquancourt, Service d anatomopathologie Cédric de Bazelaire, Service de radiologie Hôpital Saint-Louis Paris Introduction Correlation

More information

Evaluation of BI-RADS 3 lesions in women with a high risk of hereditary breast cancer.

Evaluation of BI-RADS 3 lesions in women with a high risk of hereditary breast cancer. Evaluation of BI-RADS 3 lesions in women with a high risk of hereditary breast cancer. Poster No.: C-0346 Congress: ECR 2014 Type: Scientific Exhibit Authors: A. Thomas 1, R. Dominguez Oronoz 1, S. Roche

More information

Retrospective Analysis on Malignant Calcification Previously Misdiagnosed as Benign on Screening Mammography 스크리닝유방촬영술에서양성으로진단되었던악성석회화에대한후향적분석

Retrospective Analysis on Malignant Calcification Previously Misdiagnosed as Benign on Screening Mammography 스크리닝유방촬영술에서양성으로진단되었던악성석회화에대한후향적분석 Original Article pissn 1738-2637 / eissn 2288-2928 https://doi.org/10.3348/jksr.2017.76.4.251 Retrospective Analysis on Malignant Calcification Previously Misdiagnosed as Benign on Screening 스크리닝유방촬영술에서양성으로진단되었던악성석회화에대한후향적분석

More information

Incidence and Management of Complex Fibroadenomas

Incidence and Management of Complex Fibroadenomas Incidence and Management of Complex Fibroadenomas Women s Imaging Original Research 214.fm 11/29/07 WOMEN S IMAGING Miri Sklair-Levy 1 Tamar Sella 1 Tanir Alweiss 2 Ilia Craciun 1 Eugene Libson 1 Bella

More information

Mammography and Subsequent Whole-Breast Sonography of Nonpalpable Breast Cancers: The Importance of Radiologic Breast Density

Mammography and Subsequent Whole-Breast Sonography of Nonpalpable Breast Cancers: The Importance of Radiologic Breast Density Isabelle Leconte 1 Chantal Feger 1 Christine Galant 2 Martine Berlière 3 Bruno Vande Berg 1 William D Hoore 4 Baudouin Maldague 1 Received July 11, 2002; accepted after revision October 28, 2002. 1 Department

More information

Building Blocks for Effective Report Communication

Building Blocks for Effective Report Communication 2016 SBI/ACR Breast Imaging Symposium Building Blocks for Effective Report Communication Richard L. Ellis, M.D. Breast Imaging Section Mayo Clinic Franciscan Health Care La Crosse, WI JW Marriott Austin

More information

Breast Density. Update 2018: Implications for Clinical Practice

Breast Density. Update 2018: Implications for Clinical Practice Breast Density Update 2018: Implications for Clinical Practice Matthew A. Stein, MD Assistant professor Breast Imaging Department of Radiology and Imaging Sciences University of Utah Health Disclosures

More information

THYROID NODULES: THE ROLE OF ULTRASOUND

THYROID NODULES: THE ROLE OF ULTRASOUND THYROID NODULES: THE ROLE OF ULTRASOUND NOVEMBER 2017 DR. DEAN DURANT DEFINITION Thyroid nodule: Focal area within the thyroid gland with echogenicity different from surrounding parenchyma. THYROID NODULES

More information

Accuracy of sonography BIRADS lexicon

Accuracy of sonography BIRADS lexicon Accuracy of sonography BIRADS lexicon Poster No.: C-0255 Congress: ECR 2011 Type: Authors: Keywords: DOI: Scientific Paper N. Ahmadinejad, S. Pourjabbar, M. Shakiba, A. Imanzadeh; Tehran/IR Breast, Obstretric

More information